nach oben

Diabetologia

Erschienen in:

01.12.2011 | Article

Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

verfasst von: L. Norton, M. Fourcaudot, M. A. Abdul-Ghani, D. Winnier, F. F. Mehta, C. P. Jenkinson, R. A. DeFronzo

Erschienen in: Diabetologia | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF7L2 in hepatocytes.

Methods

We investigated the effect of TCF7L2 silencing and overexpression on HGP from gluconeogenic precursors and used chromatin-immunoprecipitation (ChIP) combined with massively parallel DNA sequencing (ChIP-Seq) to investigate the DNA binding patterns of TCF7L2 across the whole genome.

Results

Silencing of TCF7L2 induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and G6pc. Overexpression of Tcf7l2 reversed this phenotype and significantly reduced HGP. TCF7L2 silencing did not affect the half-maximal inhibitory concentration of insulin or metformin, but HGP remained elevated in TCF7L2-silenced cells due to the increased baseline HGP. Using ChIP-Seq, we detected 2,119 binding events across the genome. Pathway analysis demonstrated that diabetes genes were significantly over-represented in the dataset. Our results indicate that TCF7L2 binds directly to multiple genes that are important in regulation of glucose metabolism in the liver, including Pck1, Fbp1, Irs1, Irs2, Akt2, Adipor1, Pdk4 and Cpt1a.

Conclusions/interpretation

TCF7L2 is an important regulator of HGP in vitro and binds directly to genes that are important in pathways of glucose metabolism in the liver. These data highlight the possibility that TCF7L2 may affect fasting and postprandial hyperglycaemia in carriers of at-risk TCF7L2 genetic polymorphisms.

Nur mit Berechtigung zugänglich

Duggirala R, Blangero J, Almasy L et al (1999) Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 64:1127–1140PubMedCrossRef

Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323PubMedCrossRef

Cauchi S, El Achhab Y, Choquet H et al (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85:777–782PubMedCrossRef

Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480PubMedCrossRef

Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57:645–653PubMedCrossRef

Wegner L, Hussain MS, Pilgaard K et al (2008) Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. J Clin Endocrinol Metab 93:4013–4019PubMedCrossRef

Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163PubMedCrossRef

Pilgaard K, Jensen CB, Schou JH et al (2009) The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52:1298–1307PubMedCrossRef

Gebhardt R, Hovhannisyan A (2010) Organ patterning in the adult stage: the role of Wnt/beta-catenin signaling in liver zonation and beyond. Dev Dyn 239:45–55PubMed

10.

Jungermann K (1987) Metabolic zonation of liver parenchyma: significance for the regulation of glycogen metabolism, gluconeogenesis, and glycolysis. Diabetes Metab Rev 3:269–293PubMedCrossRef

11.

Katz N, Teutsch HF, Jungermann K, Sasse D (1977) Heterogeneous reciprocal localization of fructose-1,6-bisphosphatase and of glucokinase in microdissected periportal and perivenous rat liver tissue. FEBS Lett 83:272–276PubMedCrossRef

12.

Torre C, Perret C, Colnot S (2011) Transcription dynamics in a physiological process: beta-catenin signaling directs liver metabolic zonation. Int J Biochem Cell Biol 43:271–278PubMedCrossRef

13.

Benhamouche S, Decaens T, Godard C et al (2006) Apc tumor suppressor gene is the “zonation-keeper” of mouse liver. Dev Cell 10:759–770PubMedCrossRef

14.

Braeuning A, Ittrich C, Kohle C et al (2006) Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J 273:5051–5061PubMedCrossRef

15.

de Raemy-Schenk AM, Trouble S, Gaillard P et al (2006) A cellular assay for measuring the modulation of glucose production in H4IIE cells. Assay Drug Dev Technol 4:525–533PubMedCrossRef

16.

Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK (2002) Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277:32234–32242PubMedCrossRef

17.

Gao Y, Walder K, Sunderland T et al (2003) Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells. Diabetes 52:929–934PubMedCrossRef

18.

Korinek V, Barker N, Morin PJ et al (1997) Constitutive transcriptional activation by a β-catenin–Tcf complex in APC^−/− colon carcinoma. Science 275:1784–1787PubMedCrossRef

19.

Norton L, Parr T, Chokkalingam K et al (2008) Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes. J Clin Endocrinol Metab 93:992–998PubMedCrossRef

20.

Tsedensodnom O, Koga H, Rosenberg SA et al (2011) Identification of T cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res 317:920–931PubMedCrossRef

21.

Osmark P, Hansson O, Jonsson A, Ronn T, Groop L, Renstrom E (2009) Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia 52:850–854PubMedCrossRef

22.

Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2:28–36PubMed

23.

Hatzis P, van der Flier LG, van Driel MA et al (2008) Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28:2732–2744PubMedCrossRef

24.

Bottomly D, Kyler SL, McWeeney SK, Yochum GS (2010) Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38:5735–5745PubMedCrossRef

25.

Zhao J, Schug J, Li M, Kaestner KH, Grant SF (2010) Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia 53:2340–2346PubMedCrossRef

26.

Liu Z, Habener JF (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283:8723–8735PubMedCrossRef

27.

Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M (2009) Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 49:426–435PubMedCrossRef

28.

Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 18:2388–2399PubMedCrossRef

29.

Elbein SC, Chu WS, Das SK et al (2007) Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 50:1621–1630PubMedCrossRef

30.

Nordlie RC, Foster JD, Lange AJ (1999) Regulation of glucose production by the liver. Annu Rev Nutr 19:379–406PubMedCrossRef

31.

Orho M, Bosshard NU, Buist NR et al (1998) Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest 102:507–515PubMedCrossRef

32.

Sugden MC (2003) PDK4: a factor in fatness? Obes Res 11:167–169PubMedCrossRef

33.

Conti R, Mannucci E, Pessotto P et al (2011) Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis. Diabetes 60:644–651PubMedCrossRef

34.

Zhou H, Song X, Briggs M et al (2005) Adiponectin represses gluconeogenesis independent of insulin in hepatocytes. Biochem Biophys Res Commun 338:793–799PubMedCrossRef

35.

Yoon YS, Ryu D, Lee MW, Hong S, Koo SH (2009) Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis. Exp Mol Med 41:577–583PubMedCrossRef

36.

Inukai K, Nakashima Y, Watanabe M et al (2005) Regulation of adiponectin receptor gene expression in diabetic mice. Am J Physiol Endocrinol Metab 288:E876–E882PubMedCrossRef

37.

Dong X, Park S, Lin X, Copps K, Yi X, White MF (2006) Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 116:101–114PubMedCrossRef

38.

Cadoret A, Ovejero C, Terris B et al (2002) New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21:8293–8301PubMedCrossRef

39.

Loeppen S, Schneider D, Gaunitz F et al (2002) Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res 62:5685–5688PubMed

40.

Nicholes K, Guillet S, Tomlinson E et al (2002) A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 160:2295–2307PubMedCrossRef

41.

Chafey P, Finzi L, Boisgard R et al (2009) Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics 9:3889–3900PubMedCrossRef

42.

Stanulovic VS, Kyrmizi I, Kruithof-de Julio M et al (2007) Hepatic HNF4alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. Hepatology 45:433–444PubMedCrossRef

43.

Colletti M, Cicchini C, Conigliaro A et al (2009) Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology 137:660–672PubMedCrossRef

44.

Cowie CC, Rust KF, Byrd-Holt DD et al (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 29:1263–1268PubMedCrossRef

Titel: Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism
verfasst von: L. Norton
M. Fourcaudot
M. A. Abdul-Ghani
D. Winnier
F. F. Mehta
C. P. Jenkinson
R. A. DeFronzo
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2289-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2011

Heat shock protein 27 is associated with better nerve function and fewer signs of neuropathy

Environmental pollutants and beta cell function: relevance for type 1 and gestational diabetes

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study

Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin